Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1070–1076. doi: 10.1038/bjc.1992.412

Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.

J C Bremner 1, G E Adams 1, J K Pearson 1, J M Sansom 1, I J Stratford 1, J Bedwell 1, S G Bown 1, A J MacRobert 1, D Phillips 1
PMCID: PMC1978041  PMID: 1457346

Abstract

The effect of combining photodynamic therapy (PDT) and bioreductive drugs has been investigated using the RIF-1 experimental murine tumour. Light was delivered interstially to the tumour at 675 nm using a single optical fibre attached to an argon-ion dye laser. The photosensitizer was disulphonated aluminium phthalocyanine (AlS2Pc) and the bioreductive drugs were the dual function nitroimidazole RSU1069 and its pro-drug RB6145. Varying the time between administration of the photosensitizer and light delivery (TL) from 30 min to 24 h had little influence on the extent of the anti-tumour effect of PDT alone, as measured by the regrowth delay endpoint. When the bioreductive drug was included in the treatment, administered 20 min before light irradiation, regrowth delay was greatly increased. The effectiveness of the combined treatment was optimum for short values of TL (about 1 h). Fluorescence microscopy was used to investigate the distribution of the photosensitizer within the tumours. This showed that the compound was mainly confined to the tumour vasculature over the first few hours post-treatment. The high efficacy of the combined treatment of PDT and bioreductive drugs for short values of TL suggest that photodynamic action, during the period when the photosensitizer AlS2Pc is confined to the vasculature, enhances the severity of tumour hypoxia which is sufficient to induce activation of the bioreductive drugs.

Full text

PDF
1071

Images in this article

1072Figure 1
on p.1072

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed I., Jenkins T. C., Walling J. M., Stratford I. J., Sheldon P. W., Adams G. E., Fielden E. M. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1079–1081. doi: 10.1016/0360-3016(86)90230-0. [DOI] [PubMed] [Google Scholar]
  2. Ambroz M., Beeby A., MacRobert A. J., Simpson M. S., Svensen R. K., Phillips D. Preparative, analytical and fluorescence spectroscopic studies of sulphonated aluminium phthalocyanine photosensitizers. J Photochem Photobiol B. 1991 Apr;9(1):87–95. doi: 10.1016/1011-1344(91)80006-4. [DOI] [PubMed] [Google Scholar]
  3. Braunschweiger P. G., Johnson C. S., Kumar N., Ord V., Furmanski P. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Cancer Res. 1988 Nov 1;48(21):6011–6016. [PubMed] [Google Scholar]
  4. Bremner J. C., Stratford I. J., Bowler J., Adams G. E. Bioreductive drugs and the selective induction of tumour hypoxia. Br J Cancer. 1990 May;61(5):717–721. doi: 10.1038/bjc.1990.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan W. S., Marshall J. F., Lam G. Y., Hart I. R. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Cancer Res. 1988 Jun 1;48(11):3040–3044. [PubMed] [Google Scholar]
  6. Chan W. S., Marshall J. F., Svensen R., Bedwell J., Hart I. R. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res. 1990 Aug 1;50(15):4533–4538. [PubMed] [Google Scholar]
  7. Chaplin D. J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):579–585. doi: 10.1016/0360-3016(87)90075-7. [DOI] [PubMed] [Google Scholar]
  8. Chaplin D. J. Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT). Br J Cancer. 1986 Nov;54(5):727–731. doi: 10.1038/bjc.1986.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chatlani P. T., Bedwell J., MacRobert A. J., Barr H., Boulos P. B., Krasner N., Phillips D., Bown S. G. Comparison of distribution and photodynamic effects of di- and tetra-sulphonated aluminium phthalocyanines in normal rat colon. Photochem Photobiol. 1991 Jun;53(6):745–751. doi: 10.1111/j.1751-1097.1991.tb09887.x. [DOI] [PubMed] [Google Scholar]
  10. Edwards H. S., Bremner J. C., Stratford I. J. Induction of hypoxia in the KHT sarcoma by tumour necrosis factor and flavone acetic acid. Int J Radiat Biol. 1991 Feb;59(2):419–432. doi: 10.1080/09553009114550381. [DOI] [PubMed] [Google Scholar]
  11. Edwards H. S., Bremner J. C., Stratford I. J. Induction of tumour hypoxia by FAA and TNF: interaction with bioreductive drugs. Int J Radiat Biol. 1991 Jul-Aug;60(1-2):373–377. doi: 10.1080/09553009114552181. [DOI] [PubMed] [Google Scholar]
  12. Gonzalez S., Arnfield M. R., Meeker B. E., Tulip J., Lakey W. H., Chapman J. D., McPhee M. S. Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole. Cancer Res. 1986 Jun;46(6):2858–2862. [PubMed] [Google Scholar]
  13. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
  14. Henderson B. W., Waldow S. M., Mang T. S., Potter W. R., Malone P. B., Dougherty T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985 Feb;45(2):572–576. [PubMed] [Google Scholar]
  15. Henry J. M., Isaacs J. T. Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy. J Urol. 1989 Jul;142(1):165–170. doi: 10.1016/s0022-5347(17)38704-9. [DOI] [PubMed] [Google Scholar]
  16. Hirsch B. D., Walz N. C., Meeker B. E., Arnfield M. R., Tulip J., McPhee M. S., Chapman J. D. Photodynamic therapy-induced hypoxia in rat tumors and normal tissues. Photochem Photobiol. 1987 Nov;46(5):847–852. doi: 10.1111/j.1751-1097.1987.tb04858.x. [DOI] [PubMed] [Google Scholar]
  17. Jenkins T. C., Naylor M. A., O'Neill P., Threadgill M. D., Cole S., Stratford I. J., Adams G. E., Fielden E. M., Suto M. J., Stier M. A. Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins. J Med Chem. 1990 Sep;33(9):2603–2610. doi: 10.1021/jm00171a040. [DOI] [PubMed] [Google Scholar]
  18. Korbelik M., Krosl G., Olive P. L., Chaplin D. J. Distribution of Photofrin between tumour cells and tumour associated macrophages. Br J Cancer. 1991 Sep;64(3):508–512. doi: 10.1038/bjc.1991.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nelson J. S., Liaw L. H., Orenstein A., Roberts W. G., Berns M. W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst. 1988 Dec 21;80(20):1599–1605. doi: 10.1093/jnci/80.20.1599. [DOI] [PubMed] [Google Scholar]
  20. Nuutinen P. J., Chatlani P. T., Bedwell J., MacRobert A. J., Phillips D., Bown S. G. Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer. 1991 Dec;64(6):1108–1115. doi: 10.1038/bjc.1991.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pope A. J., MacRobert A. J., Phillips D., Bown S. G. The detection of phthalocyanine fluorescence in normal rat bladder wall using sensitive digital imaging microscopy. Br J Cancer. 1991 Nov;64(5):875–879. doi: 10.1038/bjc.1991.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spikes J. D. Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol. 1986 Jun;43(6):691–699. doi: 10.1111/j.1751-1097.1986.tb05648.x. [DOI] [PubMed] [Google Scholar]
  23. Star W. M., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986 May;46(5):2532–2540. [PubMed] [Google Scholar]
  24. Stratford I. J., Adams G. E., Godden J., Nolan J., Howells N., Timpson N. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. Br J Cancer. 1988 Aug;58(2):122–127. doi: 10.1038/bjc.1988.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sun J. R., Brown J. M. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. Cancer Res. 1989 Oct 15;49(20):5664–5670. [PubMed] [Google Scholar]
  26. Tralau C. J., Barr H., Sandeman D. R., Barton T., Lewin M. R., Bown S. G. Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas. Photochem Photobiol. 1987 Nov;46(5):777–781. doi: 10.1111/j.1751-1097.1987.tb04847.x. [DOI] [PubMed] [Google Scholar]
  27. Twentyman P. R., Brown J. M., Gray J. W., Franko A. J., Scoles M. A., Kallman R. F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst. 1980 Mar;64(3):595–604. [PubMed] [Google Scholar]
  28. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]
  29. Wharen R. E., Jr, Anderson R. E., Laws E. R., Jr Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues. Neurosurgery. 1983 Apr;12(4):446–450. doi: 10.1227/00006123-198304000-00013. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES